Patent details

EP1896040 Title: PHOSPHORAMIDATE ALKYLATOR PRODRUGS.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1896040
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP06786161.7
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
29/06/2006
Grant date:
01/08/2012
EP Publication Date:
01/08/2012
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/08/2012
EP B1 Publication Date:
01/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
16/08/2012
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/06/2026
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
25/03/2024
 
 

 

Name:
ImmunoGenesis, Inc.
Address:
2450 Holcombe Blvd., Suite J, Houston, Texas 77021, United States of America (US)

Historical Applicant/holder

From:
25/03/2024
To:
25/03/2024

 

Name:
ImmunoGenesis, Inc.
Address:
2450 Holcombe Blvd., Suite J, 77021, Houston, Texas, United States of America (US)

From:
15/10/2018
To:
25/03/2024

 

Name:
Molecular Templates, Inc.
Address:
9301 Amberglen Blvd, Suite 100, 78729, AUSTIN, Texas , United States of America (US)

From:
01/08/2012
To:
15/10/2018

 

Name:
Threshold Pharmaceuticals, Inc.
Address:
1300 Seaport Boulevard, 5th Floor, REDWOOD CITY, CA 94063, United States of America (US)

Inventor

1

Name:
MATTEUCCI, Mark
Address:
PORTOLA VALLEY, CALIFORNIA 94028, United States of America (US)

2

Name:
DUAN, Jian-Xin
Address:
SO. SAN FRANCISCO, CALIFORNIA 94080, United States of America (US)

3

Name:
JIAO, Hailong
Address:
FOSTER CITY, CALIFORNIA 94404, United States of America (US)

4

Name:
KAIZERMAN, Jacob
Address:
MENLO PARK, CALIFORNIA 94026, United States of America (US)

Priority

Priority Patent Number:
695755 P
Priority Date:
29/06/2005
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C07F 9/6506;
IPC or IDT classification:
A61K 31/675; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
14/24
Publication date:
03/04/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
52/18
Publication date:
19/12/2018
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
2012/36
Publication date:
05/09/2012
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
2012/32
Publication date:
08/08/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201231
Publication date:
01/08/2012
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202400620B
Date Registered:
25/03/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
ImmunoGenesis, Inc.
Address:
2450 Holcombe Blvd., Suite J, 77021, Houston, Texas, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400723A
Date Registered:
25/03/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201801812A
Date Registered:
15/10/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Molecular Templates, Inc.
Address:
9301 Amberglen Blvd, Suite 100, 78729, AUSTIN, Texas , United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
26/06/2025
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
12/12/2018 Outgoing Correspondence Letter registration deed 1 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_5_244795l118.pdf
15/10/2018 Request for Change First filed deed 4 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_3_rfc20181016015639281.pdf
20/05/2016 Outgoing Correspondence Outgoing Letter 1 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_2_56849l181.pdf
16/08/2012 Outgoing Correspondence Outgoing Letter 1 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_0_outgoingcorrespondence20120816.pdf
16/08/2012 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_1_incomingcorrespondencepaper20120816.pdf
16/08/2012 Claims Translated claims 3 PDF /1/6/1/6/8/0506786161/docs/ep06786161.7_4_claims20120816.pdf